- Lilly concluded its first digital health open innovation challenge, “Transforming IBD Care: Better Disease Monitoring, Management, and Care for People with Inflammatory Bowel Disease,” and selected HealthVoyager as the winner.- The challenge culminated in a competition hosted at Lilly’s headquarters in Indianapolis, where five finalists presented their digital health solutions aimed at transforming IBD care to a panel of judges.Eli Lilly and Company, today announced it has named HealthVoyager,
Read More
inflammatory bowel disease (IBD)
Lilly Launches Innovation Challenge to Transform IBD Care Through Digital Health
Eli Lilly and Company (NYSE: LLY) is launching an open innovation challenge to encourage individuals and teams across the U.S. to identify and submit pioneering digital health solutions aimed at transforming inflammatory bowel disease (IBD) care. The challenge, "Transforming IBD Care: Better disease monitoring, management, and care for people with inflammatory bowel disease" focuses on innovation in IBD monitoring, condition management or care enhancements.Impact of Inflammatory Bowel Disease
Read More
Oshi Health Launches All-in-One Mobile App for IBD Management
Oshi Health, Inc. today announced the release of Oshi, a digital tracking mobile app with all-in-one features for inflammatory bowel disease (IBD) management and wellness including symptom tracking, curated learning, and expert Q&A. Oshi is now available for download on the Apple App Store or Android Google Play.Currently, there is no known cause or cure for Crohn's disease (CD) or ulcerative colitis (UC), the two main forms of IBD. Both are marked by inflammation in the lining of the
Read More
